Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Aliment Pharmacol Ther. 2009 Oct 23;31(3):424–431. doi: 10.1111/j.1365-2036.2009.04180.x

Table 1.

Baseline Characteristics of RRISK Cohort and factors associated with Irritable Bowel Syndrome

Characteristics No IBS
N (%)
IBS
N (%)
Multivariate
OR (95% CI)
P
N 1903 204
Demographics
  Age, mean +/− SD 56 ± 9 56 ± 9 0.9 (0.8 – 0.9) <0.01
  Race <0.01
    Caucasian 878 (46) 125 (61) Reference
    African-American 349 (18) 33 (16) 0.6 (0.4 – 0.9)
    Asian 332 (17) 13 (6) 0.3 (0.1 – 0.5)
    Latina and other 344 (18) 33 (16) 0.6 (0.4 – 0.9)
Medical/Surgical History
  Diabetes 151 (8) 23 (11) 1.8 (1.1 – 3.1) 0.02
  Hysterectomy 401 (21) 74 (36) 2.0 (1.4 – 2.9) <0.01
  Urinary incontinence surgery 42 (2) 8 (4) 0.5 (0.2 – 1.4) 0.17
  Pelvic organ prolapse surgery 57 (3) 18 (9) 2.5 (1.1 – 5.5) 0.02
  Colon surgery 60 (3) 18 (9) 2.5 (1.3 – 4.8) <0.01
Pelvic Floor Disorders
  Urinary urgency, ≥ weekly 446 (30) 72 (40) 1.4 (1.0 – 1.9) 0.06
  Any urinary incontinence 1346 (71) 170 (83) 1.6 (0.8 – 3.0) 0.18
    Never 557 (29) 34 (17) Ref 0.12
    Less than monthly 552 (29) 57 (28) 1.4 (0.7 – 2.9)
    Monthly 265 (14) 39 (19) 1.9 (0.9 – 3.8)
    Weekly 308 (16) 33 (16) 1.2 (0.6 – 2.5)
    Daily 221 (12) 41 (20) 2.0 (1.0 – 4.3)
Symptomatic pelvic organ
prolapse in last 12 months
93 (5) 25 (12) 2.4 (1.4 – 4.1) <0.01

IBS = Irritable Bowel Syndrome; OR = Odds Ratio; CI = Confidence Interval; SD = Standard Deviation

Variables not included in this table include, history of cancer, postmenopausal, tobacco use, oophorectomy because statistical significance of each was p>0.2 in univariate analysis

Based on a multivariate logistic regression model that included all variables shown in the table with p-values that remained less than 0.20 after adjustment.

Odds ratio for age is reported per 5 years.